Maternal care for (suspected) chromosomal abnormality in fetus, Trisomy 21
ICD-10 O35.13 is a billable code used to indicate a diagnosis of maternal care for (suspected) chromosomal abnormality in fetus, trisomy 21.
O35.13 is used to indicate maternal care for a suspected chromosomal abnormality in the fetus, specifically Trisomy 21, also known as Down syndrome. This code is relevant when prenatal screening tests, such as non-invasive prenatal testing (NIPT) or ultrasound, suggest the possibility of this genetic condition. Maternal care may involve genetic counseling, further diagnostic testing such as amniocentesis or chorionic villus sampling (CVS), and close monitoring of the pregnancy. The management of pregnancies with suspected chromosomal abnormalities often requires a multidisciplinary approach, including obstetricians, maternal-fetal medicine specialists, and genetic counselors. The goal is to provide comprehensive care and support to the mother while preparing for the potential needs of the child post-delivery. Documentation should reflect the clinical findings, the rationale for testing, and the discussions held with the patient regarding the implications of the diagnosis.
Documentation must include prenatal screening results, discussions about genetic testing, and any referrals made for genetic counseling.
Patients presenting with abnormal ultrasound findings or positive screening tests for chromosomal abnormalities.
Consideration of the emotional impact on the patient and the need for supportive counseling.
Detailed records of high-risk assessments, diagnostic testing results, and management plans.
Management of pregnancies with confirmed or suspected chromosomal abnormalities requiring specialized care.
Coordination of care among multiple providers and ensuring comprehensive follow-up.
Used during routine prenatal visits to assess fetal anatomy and detect abnormalities.
Document the findings of the ultrasound and any follow-up recommendations.
Obstetricians should ensure that the ultrasound is performed by qualified personnel and that results are communicated effectively.
Ordered when there is a suspicion of Trisomy 21 based on screening results.
Document the reason for testing and the informed consent process.
Genetic counselors may be involved in the process to provide support and information.
Documentation must include the results of any prenatal screening tests, the rationale for further diagnostic testing, and notes from genetic counseling sessions.
O35.13 specifically refers to suspected Trisomy 21. Ensure that the documentation clearly indicates the specific abnormality being addressed.
